Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bristol-Myers Squibb Co (NYSE:BMY)

60.72
Delayed Data
As of Feb 08
 +1.09 / +1.83%
Today’s Change
51.82
Today|||52-Week Range
70.87
-11.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$99.5B

Company Description

Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from biological processes called biologics. The company's biopharmaceutical research and development efforts in the affective (psychiatric) disorders, Alzheimer's/dementia, cardiovascular, diabetes, hepatitis, HIV/Acquired Immunodeficiency Syndrome (AIDS), oncology, immunologic disorders and fibrotic disease areas. Bristol-Myers Squibb was founded in August 1933 and is headquartered in New York, NY.

Contact Information

Bristol-Myers Squibb Co.
345 Park Avenue
New York New York 10154
P:(212) 546-4000
Investor Relations:

Employees

Shareholders

Mutual fund holders41.47%
Other institutional33.02%
Individual stakeholders0.31%

Top Executives

Giovanni CaforioChief Executive Officer & Director
Charles A. BancroftChief Financial Officer & Executive Vice President
Paul von AutenriedChief Information Officer & Senior Vice President
Francis M. CussChief Scientific Officer & Executive VP
Carl DeciccoHead-Discovery, Research & Development